钆塞酸增强MRI肝胆期肝内弥漫性门周高信号模式:用于肝损伤临床分层的无创影像生物标志物
回顾性纳入37例肝硬化患者,按肝胆期与T2WI上门周高信号的空间一致性将门周高信号分为A、B、C三型。A型主要与急性肝损伤相关,B/C型主要与慢性纤维化相关;DBil>37.5 μmol/L可区分A型与B/C型。
要点
- 肝胆期与T2WI门周高信号空间完全重叠(A型)提示急性肝损伤。
- 门周高信号不重叠或仅见于肝胆期(B/C型)提示慢性纤维化。
- DBil>37.5 μmol/L区分A型与B/C型,AUC 0.922,敏感度86.7%,特异度100%。
核心结论
- 基于肝胆期与T2WI空间一致性的门周高信号分型,可无创区分肝硬化患者急性炎症性与慢性纤维化性肝损伤,结合DBil阈值可作为肝损伤临床分层的生物标志物,并可能促进慢性肝病的个体化诊疗决策。
研究设计与样本
- 回顾性研究,纳入2019年10月至2023年11月间接受钆塞酸增强MRI、肝胆期显示肝内弥漫性门周高信号的37例肝硬化患者,按肝胆期与T2WI门周高信号空间一致性分为A型(完全重叠,n=21)、B型(肝胆期门周高信号紧邻T2WI高信号外侧,n=11)、C型(肝胆期有而T2WI无,n=5),比较各型病因与肝功能生化指标。
关键影像表现/征象
- A型门周高信号主要见于急性肝损伤(如急性病毒性肝炎发作、药物性肝损伤、自身免疫性肝炎)。
- B/C型门周高信号主要见于慢性纤维化疾病(如HBV/HCV相关肝硬化、原发性胆汁性胆管炎、原发性硬化性胆管炎)。
- 无动脉期高增强的肝胆期甜甜圈样结节仅见于不匹配组(B型4/11,C型3/5)。
诊断标准与关键数值
- A型:肝胆期与T2WI门周高信号区域完全空间重叠。
- B型:肝胆期门周高信号位于T2WI高信号区域紧邻外侧。
- C型:肝胆期门周高信号存在而T2WI无对应高信号。
- DBil>37.5 μmol/L区分A型与B/C型:AUC 0.922,敏感度86.7%,特异度100%。
临床应用与阅片要点
- 阅片时对照肝胆期与T2WI门周高信号的空间分布,按重叠、紧邻外侧、仅肝胆期三种模式分型。
- A型伴ALT、AST、GGT、TBil、DBil显著升高及ALT-AST强相关(r=0.95,P<0.001),提示急性肝损伤。
- B/C型伴TBil-DBil强相关(r=0.95,P<0.001)及ALP、Alb中度升高(P=0.027、P=0.017),提示慢性纤维化。
- 无动脉期高增强的肝胆期甜甜圈样结节见于不匹配组,支持其与慢性纤维化改变相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the clinicoradiological significance of intrahepatic periportal hyperintensity (PHI) detected by gadoxetate-enhanced hepatobiliary phase (HBP) MRI and T2-weighted imaging (T2WI), and to assess its potential as a noninvasive imaging biomarker for clinical stratification of liver injury in patients with cirrhosis.
METHODS: This retrospective study included 37 cirrhotic patients with intrahepatic diffuse PHI on HBP imaging, who underwent gadoxetate-enhanced MRI between October 2019 and November 2023. PHI patterns were classified into two groups based on the spatial concordance between periportal enhancement areas on HBP and periportal hyperintense areas on T2WI. The matching group (Type A, n = 21) demonstrated complete spatial overlap between the two sequences. The mismatching group, comprised Type B (n = 11), in which PHI on HBP was immediately outside of that on T2WI, and Type C (n = 5), in which PHI was present on HBP but absent on T2WI. Clinical etiologies and liver biochemical markers (ALT, AST, GGT, TBil, DBil, ALP, Alb, TP) were compared across PHI subtypes.
RESULTS: Type A PHI was predominantly associated with acute liver injury (e.g., acute viral hepatitis flares, drug-induced liver injury, autoimmune hepatitis), characterized by a strong ALT-AST correlation (r = 0.95, P < 0.001) and significantly elevated levels of ALT, AST, GGT, TBil, and DBil (all P < 0.001). In contrast, Types B and C PHI were primarily linked to chronic fibrotic conditions (e.g., HBV/HCV-related cirrhosis, primary biliary cholangitis, and primary sclerosing cholangitis), showing a strong TBil-DBil correlation (r = 0.95, P < 0.001) and moderately elevated ALP and Alb levels (P = 0.027 and P = 0.017, respectively). Receiver operating characteristic (ROC) analysis identified DBil > 37.5 μmol/L as the optimal threshold for differentiating Type A from Types B/C PHI (AUC = 0.922; sensitivity = 86.7%, specificity = 100%). Notably, HBP-doughnut nodules without arterial-phase hyperenhancement (APHE) were exclusively observed in the mismatching group (Type B: 4/11; Type C: 3/5), further supporting their association with chronic fibrotic changes.
CONCLUSION: PHI phenotyping based on HBP-T2WI spatial concordance enables accurate, noninvasive differentiation between acute inflammatory and chronic fibrotic liver injury in cirrhotic patients. When integrated with the DBil threshold, this imaging-based approach provides as a robust biomarker for clinical stratification of liver injury and may facilitate individualized diagnosis and therapeutic decision-making in chronic liver disease.
引用
- Wu F, Zhu W, Du S, et al. Intrahepatic diffuse periportal hyperintensity patterns on hepatobiliary phase of gadoxetate-enhanced MRI: a non-invasive imaging biomarker for clinical stratification of liver injury. Abdom Radiol (NY). 2025. PMID: 40358705. doi:10.1007/s00261-025-04985-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。